Prestige Biologics Co., Ltd. (KOSDAQ:334970)
1,057.00
-42.00 (-3.82%)
At close: Nov 20, 2026
| Market Cap | 82.18B -63.7% |
| Revenue (ttm) | 26.67B +112.8% |
| Net Income | -51.22B |
| EPS | -658.76 |
| Shares Out | 77.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 154,688 |
| Open | 1,099.00 |
| Previous Close | 1,099.00 |
| Day's Range | 1,041.00 - 1,120.00 |
| 52-Week Range | 1,010.00 - 3,850.00 |
| Beta | 0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |